Program

Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center
Padmanee Sharma, University of Texas MD Anderson Cancer Center

Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, Combined checkpoint blockade
Padmanee Sharma, University of Texas MD Anderson Cancer Center, Immune checkpoint therapies: clinical success and next steps
Holbrook Kohrt, Stanford Cancer Institute, Combination monoclonal antibody therapy: dual tumor and immune targeting
Steven A. Rosenberg, NCI, NIH, The curative potential of T cell transfer immunotherapy for human cancer
Pramod K. Srivastava, University of Connecticut School of Medicine, What does a host-protective tumor-specific neo-antigen look like?
Suzanne L. Topalian, Johns Hopkins University School of Medicine, PD-1 pathway blockade in cancer therapy: new frontiers

Wendy S. Garrett, Harvard School of Public Health
Yasmine Belkaid, NIAID, NIH

Yasmine Belkaid, NIAID, NIH, From mutualism to parasitism: context and consequences
Wendy S. Garrett, Harvard School of Public Health, The gut microbiome in colitis and colorectal cancer
Eric G. Pamer, Memorial Sloan Kettering Cancer Center, Microbiota-mediated defense against intestinal infections
Ami S. Bhatt, Stanford University, Exploring the composition of the human superorganism: the microbiome in an immunocompromised host
Bana Jabri, University of Chicago, Harnessing the interplay between commensals and pathogens in septic shock
Thaddeus S. Stappenbeck, Washington University School of Medicine, Commensal-host interactions in the intestine and their relationship to disease pathogenesis

Russell E. Vance, HHMI, University of California, Berkeley
Zhijian 'James' Chen, HHMI, University of Texas Southwestern Medical Center

Russell E. Vance, HHMI, University of California, Berkeley, Mechanisms and consequences of inflammasome activation
Michaela U. Gack, Harvard Medical School, RIG-I-like receptor regulation in virus infection and immunity
Edward A. Miao, University of North Carolina at Chapel Hill, Inflammasomes in host defense
Sunny Shin, University of Pennsylvania Perelman School of Medicine, Overcoming pathogen-encoded virulence activities to initiate innate immune defense
Zhijian 'James' Chen, HHMI, University of Texas Southwestern Medical Center, Innate immune sensing and signaling of cytosolic DNA
Thomas F. Gajewski, University of Chicago, Innate immune sensing of tumors via the host STING pathway

Gwendalyn J. Randolph, Washington University School of Medicine
Shannon J. Turley, Genentech

Gwendalyn J. Randolph, Washington University School of Medicine, Lymphatics in inflammatory disease
Laura Santambrogio, Albert Einstein College of Medicine, Lymph formation, circulation, and immunological role
Reinhold Förster, Hannover Medical School, Lymph node homing of immune cells via afferent lymphatics
Troy D. Randall, University of Alabama at Birmingham, Paradoxical role of the omentum in immunity to peritoneal tumors
Shannon J. Turley, Genentech, Regulation of leukocyte function and territoriality by fibroblastic reticular cells
Biju Parekkadan, Harvard Medical School, Lymph node cell therapy

Eric Meffre, Yale University
Jane Hoyt Buckner, Benaroya Research Institute at Virginia Mason

Eric Meffre, Yale University, Defects in early B cell tolerance checkpoints are common to autoimmune diseases
Jane Hoyt Buckner, Benaroya Research Institute at Virginia Mason, Mapping the immune pathways that drive T1D development
Megan Sykes, Columbia University, New approaches to understanding human allo- and autoimmune responses
Erik J. Peterson, University of Minnesota, PTPN22 promotes interferogenic signaling in myeloid cells
Edward K. Wakeland, University of Texas Southwestern Medical Center, A genomic analysis of systemic autoimmunity
Judith A. James, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Roles for impaired immune regulation in transition from preclinical autoimmunity to clinical lupus

Michael L. Dustin, University of Oxford
Janis K. Burkhardt, Children's Hospital of Philadelphia and University of Pennsylvania

Michael L. Dustin, University of Oxford, Novel signals in the immunological synapse
Janis K. Burkhardt, Children's Hospital of Philadelphia/University of Pennsylvania, Cytoskeletal control of integrin activation at the immunological synapse
Morgan Huse, Memorial Sloan Kettering Cancer Center, Lipid-based patterning of the immunological synapse
Clotilde Théry, INSERM U932 / Institut Curie, Exosomes and other extracellular vesicles in communication between tumors and the immune system
Anna Huttenlocher, University of Wisconsin, Imaging inflammation: implications to human disease
Thorsten R. Mempel, Massachusetts General Hospital/Harvard Medical School, Immune cell communication in the tumor environment

Steven F. Ziegler, Benaroya Research Institute
Claudia Mauri, University College London

Andrea Cerutti, Mount Sinai School of Medicine, IgD: an ancestral regulator of Th2 immune responses
Jennifer L. Gommerman, University of Toronto, Befuddled B cells and EAE pathogenesis
Claudia Mauri*, University College London, Microbiota, regulatory B cells, and arthritis: insight into a new mechanism of regulation
* Supported by the British Society for Immunology
Mitchell Kronenberg, La Jolla Institute for Allergy & Immunology, Natural killer T cells: one specificity, but different functions
Liang Zhou, Northwestern University, Regulation of Tregs in the mucosal tissues
Steven F. Ziegler, Benaroya Research Institute, Development and function of regulatory T cells

William C. Gause, New Jersey Medical School, Rutgers, The State University of New Jersey
De'Broski R. Herbert, University of California, San Francisco

De'Broski R. Herbert, University of California, San Francisco, The helminthic harangue on immunity and repair
Amariliz Rivera, New Jersey Medical School, Rutgers, The State University of New Jersey, Inflammatory monocytes orchestrate innate antifungal immunity in the lung
William C. Gause, New Jersey Medical School, Rutgers, The State University of New Jersey, Helminths, wound healing, and worm expulsion
Padraic Fallon, Trinity College Dublin, Helminth activation of innate and adaptive immunity to achieve chronic infections
P'ng Loke, NYU School of Medicine, Alternatively activated macrophages derived from monocytes and tissue-resident macrophages during helminth infections
Edward J. Pearce, Washington University School of Medicine, The metabolic regulation of alternative macrophage activation

Linda A. Sherman, Scripps Research Institute, AAI President

M. Michele Hogan, AAI Executive Director

Linda A. Sherman, Scripps Research Institute, AAI President

Linda A. Sherman, Scripps Research Institute, AAI President

Linda A. Sherman, Scripps Research Institute, AAI President

Virginia Shapiro, Mayo Clinic, AAI Committee on the Status of Women Chair

Linda A. Sherman, Scripps Research Institute, AAI President

Linda A. Sherman, Scripps Research Institute, AAI President

Robert L. Modlin, UCLA
Angela Colmone, Science Translational Medicine, AAAS

Alan Sher, NIAID, NIH, A host-directed therapy for TB infection that targets innate cytokines
Hana Golding, CBER FDA, Novel methods for measuring antibody affinity, epitope diversity, and cross-reactivity in human vaccine trials
Drew M. Pardoll, Johns Hopkins School of Medicine, Therapeutic manipulation of the microenvironment of cancer
Jeffrey A. Bluestone, University of California, San Francisco, Rebalancing the immune system through Treg biology
Angela Colmone, Science Translational Medicine, AAAS, Translational immunology research: into the future

Clifford V. Harding, Case Western Reserve University; AAI Committee on Public Affairs Chair

William Chambers, National Vice President, Extramural Research, American Cancer Society, The role of charitable and patient advocacy organizations in funding biomedical research
Gwen Nguyen, Cause Director, Indiegogo, How crowdfunding can support biomedical research
Bruce Walker, Director, Ragon Institute of MGH, MIT and Harvard; Professor, Harvard University; and Investigator, Howard Hughes Medical Institute, The role of philanthropy in supporting biomedical research
Daniel Rotrosen, Director, Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, Recent trends in NIAID-funded, investigator-initiated immunology research

Nandita Bose, Biothera

Jason Fontenot, Principal Scientist, Immunology, Biogen Idec
Brian Johnson, Director, Market Development & Product Management, Thermo Fisher Scientific
Andy I. Kokaji, Senior Scientist, STEMCELL Technologies, Inc.
Isharat Yusuf, Research Investigator II, Genomics Institute of the Novartis Research Foundation

Virginia Shapiro, Mayo Clinic; AAI Committee on the Status of Women Chair

Cherié L. Butts, Biogen-Idec; AAI Minority Affairs Committee Chair

Cherié L. Butts, Biogen-Idec; AAI Minority Affairs Committee Chair

Gabriel Núñez, University of Michigan, Linking pathogen virulence, immunity, and the microbiota

Wendy L. Havran, Scripps Research Institute
Maria-Luisa Alegre, University of Chicago

Jian Han, HudsonAlpha Institute for Biotechnology, NextGen sequencing of immune repertoire: technology, applications, and challenges
Russell G. Jones, McGill University, Metabolomics in immunity
Melody A. Swartz, University of Chicago, Immunoregulatory roles of lymphatic endothelium and their transport functions
Kevin J. Tracey, The Feinstein Institute for Medical Research, Evolutionary integration of neural and immune pathogen sensing and response

Eugene M. Oltz, Washington University School of Medicine
Pamela J. Fink, University of Washington School of Medicine

Eugene M. Oltz, Washington University School of Medicine, Composing a masterpiece: make your data sing
Robert L. Fairchild, Cleveland Clinic, My most excellent paper was returned with serious reviewer issues: what do I do now?
Pamela J. Fink, University of Washington School of Medicine, How to stay on the right side of the ethics divide

Laurel J. Gershwin, University of California, Davis
Crystal Loving, National Animal Disease Center, ARS, USDA

W. Ray Waters, National Animal Disease Center, Vaccine approaches for bovine tuberculosis: correlates of protection and relevance to human tuberculosis
Volker Gerdts, Vaccine and Infectious Disease Organization-InterVac, University of Saskatchewan, Large animal models for human vaccine research: pertussis, RSV, and others
Barney S. Graham, Vaccine Research Center, NIAID, NIH, Structure-guided development of an RSV vaccine
Crystal Loving, National Animal Disease Center, ARS, USDA, Provocation versus protection: immune responses and differential outcomes following influenza virus vaccination and challenge in pigs

Mansoor Ahmed, NCI, NIH
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University

Mansoor Ahmed, NCI, NIH, Welcome/Introduction to the Guest Symposium
Gayle E. Woloschak, Northwestern University, Introduction: Information on Radiation Research Society (RRS)
Ralph R. Weichselbaum, University of Chicago Medicine, Basic radiation biology: fatal attraction for immunologists
Yang-Xin Fu, University of Chicago, Immunologist's experiences of collaborating with the field of radiation biology
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University, Opportunities for immunology in clinical radiotherapy
Fernando Macian-Juan, Albert Einstein College of Medicine of Yeshiva University, Use of focused ultrasound to prevent immune escape

Alison Deckhut Augustine, NIAID, NIH
Ashley Xia, NIAID, NIH

Atul J. Butte, Stanford University, Translating a trillion points of data into therapies, diagnostics, and new insights into disease
Steven H. Kleinstein, Yale University, Analysis of B cell antibody repertoires from next-generation sequencing
Anjana Rao, La Jolla Institute for Allergy and Immunology, Genomics approaches to understanding immune function
Martin S. Zand, University of Rochester, Start making sense: visualization and modeling of high-dimensional data

Anjali Singh, NIAID, NIH
Alan Schultz, NIAID, NIH

David M. Asmuth, University of California, Davis
Michael R. Betts, University of Pennsylvania
Daniel C. Douek, NIAID, NIH
Mimi Ghosh, George Washington University
Ashley T. Haase, University of Minnesota
Jonathan A. Harton, Albany Medical Center
Eric Hunter, Emory University
Jeffrey D. Lifson, Leidos Biomedical Research, Inc.
Dan R. Littman, New York University School of Medicine
Bonnie J. Mathieson, NIH
Christopher J. Miller, University of California, Davis
Kristen A. Porter, NIAID, NIH
Barbara L. Shacklett, University of California, Davis

Janko Nikolich-Zugich, University of Arizona College of Medicine
Rebecca A. Fuldner, NIA, NIH

Nancy R. Manley, University of Georgia, Too much is not enough: Foxn1 and the maintenance of the postnatal thymus
Jorg J. Goronzy, Stanford University, miRNA regulation of T cell responses in older individuals
Janko Nikolich-Zugich, University of Arizona College of Medicine, Age-related changes in metabolic programming and trafficking of T cells: lessons from parabiosis
Donna M. Murasko, Drexel University, Enhanced IgG response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1

Michael C. Humble, NIEHS, NIH
B. Paige Lawrence, University of Rochester

John B. Barnett, West Virginia University, Long-term changes in the immune system due to prenatal cadmium exposure
B. Paige Lawrence, University of Rochester, The environmental legacy of pollutants: linking developmental exposures to perturbations in antiviral immune responses
Kari C. Nadeau, Stanford University, Mechanistic approaches to epigenetics and toxicant exposures
Judith T. Zelikoff, New York University School of Medicine, Maternal inhalation of ambient particulate matter causes alterations in immune profiles and anti-tumor mechanisms in juvenile murine offspring

Laurel J. Gershwin, University of California, Davis
Crystal Loving, National Animal Disease Center, ARS, USDA

W. Ray Waters, National Animal Disease Center, ARS, USDA, Vaccine approaches for bovine tuberculosis: correlates of protection and relevance to human tuberculosis
Volker Gerdts, Vaccine and Infectious Disease Organization-InterVac, University of Saskatchewan, Large animal models for human vaccine research: pertussis, RSV, and others
Barney S. Graham, Vaccine Research Center, NIAID, NIH, Structure-guided development of an RSV vaccine
Crystal Loving, National Animal Disease Center, ARS, USDA, Provocation versus protection: immune responses and differential outcomes following influenza virus vaccination and challenge in pigs

Vikki M. Abrahams, Yale School of Medicine
Mukesh K. Jaiswal, Rosalind Franklin University of Medicine and Science

Emmet Hirsch, NorthShore University Health System, Autophagy in preterm labor
Vikki M. Abrahams, Yale School of Medicine, Mechanisms of placental inflammation in obstetric antiphospholipid syndrome
Mukesh K. Jaiswal, Rosalind Franklin University of Medicine and Science, IL-22 prevents lipopolysaccharide-induced preterm labor in mice
Gil Mor, Yale School of Medicine, Role of placenta type I interferon on polymicrobial infection-induced preterm birth

Mandy L. Ford, Emory University
Maria-Luisa Alegre, University of Chicago

Donna L. Farber, Columbia University Medical Center, Tissue-resident human memory T cells in transplantation and immunity
Kimberly D. Klonowski, University of Georgia, IL-15-mediated control of memory T cell glycosylation and trafficking
Daniel Kreisel, Washington University in St. Louis, Tolerogenic role of central memory T cells in lung transplantation
Bryna Burrell, Immune Tolerance Network, Laminins affect T cell trafficking and allograft fate

Irah L. King, McGill University
Jude E. Uzonna, University of Manitoba

Jun Wang, Dalhousie University, Diverse immune mechanisms for shaping anti-Chlamydia CD4 T cell responses
Simona Stäger, INRS-Institut Armand Frappier, The role of inflammation in regulating the development of T cell responses during leishmaniasis
Irah L. King, McGill University, The role of integrins in T follicular helper cell maintenance following helminth infection
S. M. Mansour Haeryfar, University of Western Ontario, Invariant T cell responses to bacterial superantigens
Jude E. Uzonna, University of Manitoba, MHC class II-restricted innate-like double negative T cells display memory characteristics and contribute to optimal anti-Leishmania immunity

Zhigang Tian, University of Science and Technology of China
Olivera J. Finn, University of Pittsburgh School of Medicine

Zhigang Tian, University of Science and Technology of China, Development and differentiation of liver-resident NK cells
Bing Sun, Institute Pasteur of Shanghai, Chinese Academy of Sciences, Extracellular Matrix Protein 1 plays a critical role in driving Th2 cell migration and controlling Th17 cell differentiation
Liwei Lu, University of Hong Kong, Regulatory B cells in autoimmunity
Hai Qi, Tsinghua University, Follicular T helper cells and germinal center reaction
Zhongjun Dong, Tsinghua University, Metabolic regulation of NK cell development and activation

Hans-Martin Jäck, University of Erlangen
Dieter Kabelitz, University of Kiel
Carsten Watzl, Leibniz Research Center, Dortmund

Jürgen Wienands, University of Göttingen, Immunology in Germany
Tim Sparwasser, University of Hannover, Metabolic influences that regulate CD4 T cell function
Vigo Heissmeyer, University of Munich, Post-transcriptional control of Th17 differentiation
Petra Hoffmann, University of Regensburg, Impact of Treg cell plasticity on adoptive cell therapies
Jochen Hühn, Helmholtz Society, Braunschweig, Epigenetic control of regulatory T cell development
Michael Lohoff, University of Marburg, The role of interferon regulatory factors for T cell subset differentiation

Andrea J. Tenner, University of California, Irvine
Joshua M. Thurman, University of Colorado School of Medicine

Claudia Kemper, King's College London, Regulation of T lymphocyte programming by autocrine complement
Brian Geisbrecht, Kansas State University, Utilization of complement evasion strategies by pathogens
Susan Lea, University of Oxford, Illuminating mechanisms of complement-pathogen interactions from structural biology
V. Michael Holers, University of Colorado School of Medicine, Targeting complement and its activation mechanisms: successful interventions in human disease and new strategies going forward

Sarah L. Gaffen, University of Pittsburgh
Federica Sallusto, Institute for Research in Biomedicine

Partha S. Biswas, University of Pittsburgh, Cytokine deregulation in chronic kidney diseases
Federica Sallusto, Institute for Research in Biomedicine, Polarized T cell responses to pathogens and vaccines
Andrew N. McKenzie, Cambridge Immunology Network, Type-2 innate lymphoid cells at the interface with adaptive immunity
Curt M. Horvath, Northwestern University, Regulation of viral RNA recognition, innate immune signaling, and antiviral gene expression

Toshinori Nakayama, Chiba University
Ryoji Yagi, Chiba University

Yosuke Kurashima, University of Tokyo, Analysis of a mast cell-suppressive milieu on the body surface for the prevention and treatment of inflammatory diseases
Satoshi Nishimura, Jichi Medical University, Immune cell activation in obese adipose tissue: visualization by two photon microscopy
Yoshiki Omatsu, Kyoto University, Molecular mechanism of formation of bone marrow niche for hematopoietic stem/progenitor cells and immune cells
Takashi Satoh, Osaka University, The physiological role and differentiation mechanism of disorder-specific M2 macrophages
Ryoji Yagi, Chiba University, Role of the transcription factor GATA3 in helper T cell and innate lymphoid cell development
Toshinori Nakayama, Chiba University, Pathogenic memory Th2 cells in airway inflammation

Booki Min, Cleveland Clinic Foundation
Chong-Kil Lee, Chungbuk National University

Woong-Kyung Suh, Clinical Research Institute of Montreal, Dissection of inducible costimulator (ICOS) signaling components in follicular helper T cell and Th17 responses
Eun Young Choi, Seoul National University, CD8 T cells can generate memory cells without CD4 help when antigen is cleared early enough
Sang-Moo Kang, Georgia State University, Roles of innate and adaptive immune components in inducing protective immune responses to influenza vaccination
Myoung Ho Jang, Institute for Basic Science, Pohang, Eosinophils regulate inflammation in the gut

Mansoor Ahmed, NCI, NIH
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University

Mansoor Ahmed, NCI, NIH, Welcome/Introduction to the Guest Symposium
Gayle E. Woloschak, Northwestern University, Introduction: Information on Radiation Research Society (RRS)
Ralph R. Weichselbaum, University of Chicago Medicine, Basic radiation biology: fatal attraction for immunologists
Yang-Xin Fu, University of Chicago, Immunologist's experiences of collaborating with the field of radiation biology
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University, Opportunities for immunology in clinical radiotherapy
Fernando Macian-Juan, Albert Einstein College of Medicine of Yeshiva University, Use of focused ultrasound to prevent immune escape

Brian A. Cobb, Case Western Reserve University School of Medicine
James P. Paulson, Scripps Research Institute

Robert M. Anthony, Massachusetts General Hospital, Glycoregulation of immunoglobulins
Charles J. Dimitroff, Brigham and Women’s Hospital, Galectin-1 binding glycans play a pleiotropic role in melanoma development
Eugene C. Butcher, Stanford School of Medicine, Carbohydrate addressins for lymphocyte homing
Paula A. Videira, NOVA Medical School, Immunomodulation of dendritic cells: cracking the role of sialic acid-containing sugars
Vijay K. Kuchroo, Brigham and Women’s Hospital, Tim-3 and Galectin-9: regulators of effector and Treg cells

Lisa H. Butterfield, University of Pittsburgh
Augusto C. Ochoa, Louisiana State University Health Sciences Center

Lisa H. Butterfield, University of Pittsburgh, Immune biomarkers in clinical trials
Augusto C. Ochoa, Louisiana State University Health Sciences Center, Metabolism in the immune response to cancer
Giorgio Trinchieri, NCI, NIH, Omics platforms and systems biology in biomarker identification
Holden T. Maecker, Stanford University Medical Center, High dimensional cellular and proteomic profiling approaches

Louis B. Justement, University of Alabama at Birmingham
Silvia M. Uriarte, University of Louisville

Joshua J. Obar, Montana State University, Leukotriene and IL-1alpha-mediated orchestration of the antifungal leukocyte response to Aspergillus fumigatus
I. Coy Allen, Virginia Polytechnic Institute and State University, Evaluating NLR modulation of canonical and non-canonical NF-κB signaling in IBD
Laura M. Sly, University of British Columbia, Harnessing macrophage phenotype for anti-inflammatory therapy
Madhavi J. Rane, University of Louisville, Baclofen, a GABA_BR agonist, ameliorates immune-complex-mediated acute lung injury by modulating pro-inflammatory mediators
Ilhem Messaoudi Powers, University of California, Riverside, Dose-dependent modulation of immune response to vaccination by alcohol
Silvia M. Uriarte, University of Louisville, Neutrophils and oral pathogens: opposing forces in the dysbiosis battle

Timothy L. Denning, Georgia State University
Marielle C. Gold, Oregon Health & Science University

Ivaylo I. Ivanov, Columbia University, Control of mucosal Th17 cell homeostasis
Florence Lambolez, La Jolla Institute for Allergy and Immunology, DN TCRαβ⁺ IEL: mix and match MHC reactivities
Richard S. Blumberg, Harvard Medical School, NKT cells orchestrate critical barrier protective functions in mucosal tissues
Marielle C. Gold, Oregon Health & Science University, Human pathogen-reactive MAIT cells

Christine A. Biron, Brown University
Eric O. Long, NIAID, NIH

Eric O. Long, NIAID, NIH, Negative signaling by NK cell inhibitory receptors
Sungjin Kim, Michigan State University, Antibody-dependent memory-like NK cells
Joseph C. Sun, Memorial Sloan Kettering Cancer Center, Novel role for RAG in NK cells
David K. Finlay, Trinity College Dublin, Metabolic regulation of NK cell responses
Emily M. Mace, Baylor College of Medicine, The structure and function of the NK cell developmental synapse

Barbara S. Nikolajczyk, Boston University School of Medicine
Gerald V. Denis, Boston University School of Medicine

Derek M. Huffman, Albert Einstein College of Medicine, Obesity, aging, and the intestinal stem cell niche
Daniela Frasca, University of Miami, Obesity, aging, and antibody responses
Marissa J. Schafer, Mayo Clinic, Cellular senescence: at the crossroads of aging, obesity, and exercise
Shai Shen-Orr, Technion-Israeli Institute of Technology, Cellular immune response to chronic inflammation
Martin S. Obin, Tufts University, Caloric restriction and immune function in aging humans

Tina McIntyre, Scientific Review Officer, Innate Immunity and Inflammation Study Section, Immunology Integrated Review Group, Center for Scientific Review, NIH
Alison Deckhut-Augustine, Chief, Basic Immunology Branch, Division of Allergy, Immunology, and Transplantation, NIAID, NIH

Deborah Hodge, Scientific Review Officer, Immunology Fellowships and AREA Study Section, Immunology Integrated Review Group, DPPS, Center for Scientific Review
Jin Huang, Scientific Review Officer, Tumor Tolerance and Transplantation Study Section, Immunology Integrated Review Group, DPPS, Center for Scientific Review
Nancy Vazquez-Maldonado, Scientific Review Officer, Immunology Review Branch, NIAID, NIH
Lakshmi Ramachandra, Scientific Review Officer, Immunology Review Branch, NIAID, NIH

Nandita Bose, Biothera

Jason Fontenot, Principal Scientist, Immunology, Biogen Idec
Brian Johnson, Director, Market Development & Product Management, Thermo Fisher Scientific
Andy I. Kokaji, Senior Scientist, STEMCELL Technologies, Inc.
Isharat Yusuf, Research Investigator II, Genomics Institute of the Novartis Research Foundation

Virginia Shapiro, Mayo Clinic; AAI Committee on the Status of Women Chair

Cherié L. Butts, Biogen-Idec; AAI Minority Affairs Committee Chair

Derek Haseltine, Director, Career Services, College of Professional Studies, George Washington University

Derek Haseltine, Director, Career Services, College of Professional Studies, George Washington University

James Gould, Director, Office for Postdoctoral Fellows, Harvard Medical School